My watch list
my.chemeurope.com  
Login  

Biotage AB Signs Two Exclusive Agreements with Reaxa

20-Jan-2006

Under a first agreement between Reaxa and Biotage both companies will develop "MicroEnCat(tm)" an encapsulated palladium catalyst range optimized for use in Biotage's Microwave Synthesizers, including the development of prefilled microwave vials and flow-through devices. A second agreement offers Reaxa's macroporous QuadraPure(tm) metal scavenging resins conveniently prepacked in Biotage FLASH purification cartridges. These two -products reduce metal concentrations to low PPM levels facilitating multi-step synthesis and accurate scavenging.

Facts, background information, dossiers
More about Biotage
  • News

    Biotage Awarded Patent for Flash Purification Method Development and Optimization

    Biotage announced it has recently been awarded U.S. patent 7686959: Control system and Method for Flash Separation. The patented technology converts thin-layer chromatography (TLC) compound retention data into a linear gradient and also provides the user with sample loading estimates for an ... more

    Biotage AB Increases Focus on Environmental Market Segments

    Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application areas. In late 2007 Biotage launched EVOLUTE ... more

    Biotage AB acquires rights to novel Evaporation system from Vapourtec, Ltd.

    Biotage has acquired the exclusive distribution, production and further development rights to Vapourtecs solvent evaporation system, known as the V-10. The agreement also provides for Vapourtec to deliver further developments and line extensions for the product within 2006. The purchase pr ... more

  • Companies

    Biotage AB

    Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The c ... more

    Biotage, LLC

    Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The c ... more

More about Reaxa
  • News

    Reaxa Completes Second Round Funding

    Catalyst technologies company Reaxa has completed second round financing for the next stage of its commercial expansion programme. The Manchester-based company received Venture Capital from the North West Business Investment Scheme managed by YFM Private Equity (YFM), Rising Stars Growth Fu ... more

    Biotage AB Signs Two Exclusive Agreements with Reaxa

    Under a first agreement between Reaxa and Biotage both companies will develop "MicroEnCat(tm)" an encapsulated palladium catalyst range optimized for use in Biotage's Microwave Synthesizers, including the development of prefilled microwave vials and flow-through devices. A second agreement ... more

    Reaxa - New Catalyst Technologies Company Launched

    Reaxa Limited, the new catalyst technologies company, formally commenced trading following a successful spin-out from Avecia. Reaxa offers new product platforms for "easier, faster and cleaner chemistry" in pharmaceutical and specialty chemical production. Reaxa is a combined venture betwe ... more

  • Companies

    Reaxa Limited

    more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE